Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2000
08/03/2000WO2000044388A1 Modulation of immune response by ribavirin
08/03/2000WO2000044383A1 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives
08/03/2000WO2000044375A1 Antioxidant compositions and methods for companion animals
08/03/2000WO2000044371A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000WO2000044364A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
08/03/2000WO2000044361A2 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
08/03/2000WO2000044353A1 Pharmaceutical compositions
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000027850A3 Crf receptor antagonists and methods relating thereto
08/03/2000WO2000023471A3 Use of a cytokine-producing lactococcus strain to treat colitis
08/03/2000WO2000023407A3 Ureido-thiobutyric acid derivatives as ppar-agonists
08/03/2000WO2000021520A3 Opioid analgesic
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO2000006146A9 Substituted anilide compounds and methods
08/03/2000WO1999026942A8 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
08/03/2000CA2730386A1 Formulations comprising antisense nucleotides to connexins
08/03/2000CA2361614E Compositions for treating inflammatory response
08/03/2000CA2361518A1 Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha.
08/03/2000CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000CA2361246A1 Identification of specific differentially expressed antigens
08/03/2000CA2360689A1 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives
08/03/2000CA2360674A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000CA2360671A1 P53 inhibitors and therapeutic use of the same
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2360019A1 Anti-ccr1 antibodies and methods of use therefor
08/03/2000CA2359011A1 Thiazolopyrimidine compound, its production and use
08/03/2000CA2357735A1 Modulation of immune response by ribavirin
08/03/2000CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000CA2355735A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/02/2000EP1024137A1 Resolution of amines
08/02/2000EP1023902A1 Pharmaceutical preparation for the treatment of inflammatory processes
08/02/2000EP1023445A1 Cadherin derived growth factor and the application thereof
08/02/2000EP1023444A1 Cell division regulators
08/02/2000EP1023323A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
08/02/2000EP1023322A1 Novel npy family member
08/02/2000EP1023301A1 A heterocyclic chemical compound
08/02/2000EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000EP1023277A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy
08/02/2000EP1023268A1 Isoquinolines as urokinase inhibitors
08/02/2000EP1023266A2 Process for making diaryl pyridines useful as cox-2 inhibitors
08/02/2000EP1023263A1 Novel vitamin d analogues
08/02/2000EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP1023073A1 Vitronectin receptor antagonist
08/02/2000EP1023066A1 Novel pyrazole and pyrazoline substituted compounds
08/02/2000EP1023049A1 Preparation of a directly mouldable tabletting auxiliary
08/02/2000EP0873351B1 Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
08/02/2000EP0758889B1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients
08/02/2000EP0731796B1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
08/02/2000EP0613373B1 Risedronate delayed-release compositions
08/02/2000CN1261895A Cyclic azapeptide with angiogenic effect
08/02/2000CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000CN1261885A 2-substituted 4,5-diaryl imidazoles
08/02/2000CN1261882A Polymorphic form of tachykinin receptor antagonist 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl) phenyl) ethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-5(oxo-1H,4H-1,2,4-triazolo methylmorpholine
08/02/2000CN1261878A New cysteine derivatives processes for their production, and pharmaceuticals containing them
08/02/2000CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
08/02/2000CN1261795A Compounds and methods
08/02/2000CN1055089C Intermediate of protein kinase C inhibitor and its preparation
08/02/2000CN1055013C Method for prepn. of Chinese medicinal external application ointment for diminishing inflammation
08/02/2000CN1055004C External use adhesive plaster for treatment of rheumatism
08/02/2000CN1054986C Chinese medicine pill for treating rheumatoid disease
08/01/2000US6096902 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
08/01/2000US6096753 Substituted pyrimidinone and pyridone compounds and methods of use
08/01/2000US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases
08/01/2000US6096739 Treatment for CNS injuries
08/01/2000US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents
08/01/2000US6096305 Receptor that binds IL-17
08/01/2000CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
08/01/2000CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/01/2000CA2151618C Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
08/01/2000CA2140887C New nimesulide salt cyclodextrine inclusion complexes
08/01/2000CA2134240C Novel peptide having elastase inhibitor activity and process for producing the same
08/01/2000CA2019335C Phenylalkan (en)oic acids
07/2000
07/29/2000CA2260397A1 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil
07/28/2000CA2297464A1 Pharmaceutical preparation for the treatment of inflammatory processes
07/27/2000WO2000043495A2 33 human secreted proteins
07/27/2000WO2000043419A2 Exocytosis pathway proteins and methods of use
07/27/2000WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043404A1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
07/27/2000WO2000043395A1 Substituted porphyrins
07/27/2000WO2000043393A1 Novel angiogenesis inhibitors
07/27/2000WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents
07/27/2000WO2000043378A1 New morpholinobenzamide salts
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043350A1 Crystal polymorphism of aminoethylphenoxyacetic acid derivative
07/27/2000WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000WO2000043040A1 Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies
07/27/2000WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response
07/27/2000WO2000043023A1 Pharmaceutical composition with adhesion molecule expression regulating activity
1 ... 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 ... 1272